Morgan Stanley says Best Buy's healthcare strategy could yield up to $46 billion. Here's how the consumer-tech giant plans to win a slice of the $3.5 trillion industry.
, the consumer electronics giant, is entering the US healthcare market by focusing on using technology to help care for seniors. And analysts at Morgan Stanley think the company will reveal new details about its ambitions at an investor event on Wednesday.
Walmart, for instance, is planning to build health clinics to offer a breadth of services conveniently and at cheaper prices than its rivals. In 2018, That focus on technology for seniors helps Best Buy stand apart from other firms exploring health clinics or new ways to dispense medication.US Census Bureau
Looking at long-term growth, the analysts note that Best Buy serves seniors who want to live at home as well as their caregivers. The company could also benefit by convincing insurers to pay for some of its services, the analysts said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
This Is the Best Dish Rack Money Can BuyWe tested 13 dish racks to determine which is the best at keeping your dishes—and your countertop—dry.
Consulte Mais informação »
25 Things VSCO Girls Will Probably Want To Buy Right NowPrepare to sksksksk
Consulte Mais informação »
Why Americans Don’t Buy Electric Cars (Hey, The Tesla Model 3 Isn’t That Popular)Most Americans aren’t interested in electric vehicles.
Consulte Mais informação »
The rise of 'buy now, pay later''Buy now, pay later' services are not new — but what makes Klarna different is that many of its options do not charge the consumer any interest or fees. Instead, it charges retailers a transaction fee and a percentage of the sale.
Consulte Mais informação »
How to Buy Art for Any Space in Your HomeThe chicest buys for your home, no matter the size of the space.
Consulte Mais informação »
Buy Boston Beer because its spiked seltzer Truly is riding the White Claw wave, says GuggenheimGuggenheim reiterated its buy rating on Boston Beer Company's stock and raised its price target to $462 from $449 per share.
Consulte Mais informação »